Αποτελέσματα Αναζήτησης
1 ημέρα πριν · In 2022 alone, there were approximately 2.4 million new cases and 1.8 million deaths from lung cancer globally. Non-small cell lung cancer is the most common type of lung cancer, accounting for ...
12 Απρ 2024 · The key breakthrough, says Robert Winn, a lung cancer specialist at Virginia Commonwealth University, is the ability to better pinpoint the mutations of a patient's particular form of...
4 Μαρ 2024 · For advanced stage NSCLC, the number of EMA-approved targeted therapies for patients with metastatic lung cancer have increased rapidly over the past two decades and is expected to continue to grow quickly in the future.
24 Μαΐ 2021 · Update: On May 28, 2021, the US Food and Drug Administration granted accelerated approval to sotorasib (Lumakras TM) for the treatment of advanced non-small cell lung cancer driven by the KRAS -G12C mutation in patients who have already received at least one other treatment.
5 Ιουν 2024 · Osimertinib, produced by AstraZeneca under the brand name Tagrisso, significantly extends the time patients live without their cancer worsening, offering the first effective therapy and new hope...
New Frontiers in Small Cell Lung Cancer Treatment at Moffitt Cancer Center – First in U.S. to Treat Patients with New T Cell Therapy Tarlatamab. At Moffitt, we are dedicated to advancing the treatment of small cell lung cancer (SCLC), a highly aggressive and rapidly progressing form of lung cancer. SCLC is characterized by its distinct ...
31 Μαΐ 2024 · Patients with an incurable form of lung cancer could lead normal lives by taking a daily pill that “stops cancer in its tracks”, a breakthrough study has revealed. Scientists have hailed the drug,...
